- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
NEW YORK ( TheStreet) -- Genomic Health (Nasdaq: GHDX) hit a new 52-week high Tuesday as it is currently trading at $35.01, above its previous 52-week high of $35 with 140,090 shares traded as of 1:19 p.m. ET. Average volume has been 169,100 shares over the past 30 days. Genomic Health has a market cap of $1.04 billion and is part of the health care sector and health services industry. Shares are up 36.1% year to date as of the close of trading on Friday. Genomic Health, Inc., a molecular diagnostics company, engages in the development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. The company has a P/E ratio of 119.2, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.